Latest Search
Quote
| Back Zoom + Zoom - | ||||
|
<Research>HSBC Research Maintains Confidence in HKEX (00388.HK) Mid-to-Long Term Outlook, Keeps Buy Rating
Recommend 10 Positive 16 Negative 9 |
||||
|
||||
|
Recent events targeting listing execution in Hong Kong, including the ICAC's investigation into broker misconduct, rumors of restrictions on red-chip firms' listings, guidelines limiting the number of IPO applications investment banks can handle simultaneously, and the SFC's concerns over the decline in the quality of IPO applications in 2H25, have raised investor concerns about the outlook for HKEX (00388.HK), HSBC Global Research issued a research report saying. Given the expected substantial capital inflows, the broker remained confident in HKEX's mid-to-long term outlook, and added that HKEX's IPO fundraising reached approx. $100 billion YTD, with the potential to surpass $285 billion in 2025. Therefore, HSBC Global Research kept rating at Buy and a target price of $520 for HKEX, and raised its 2026-2028 earnings forecasts for HKEX by 1-3%, reflecting strong capital inflows, growth in average daily turnover and higher investment income. AASTOCKS Financial News Website: www.aastocks.com |
||||
Copied to Clipboard
 |
||||
